1.18
5.36%
+0.06
ImmunoPrecise Antibodies Ltd Aktie (IPA) Neueste Nachrichten
Should ImmunoPrecise Antibodies (CVE:IPA) Be Disappointed With Their 23% Profit? - Yahoo Lifestyle UK
Yahoo Lifestyle UK
ImmunoPrecise Antibodies And InterSystems Partner To Leverage AI In Life Sciences, Transforming Patient Care With ... - AccessWire
AccessWire
InterSystems and IPA's Subsidiary BioStrand Collaborate to Unveil the Innovative Integration of Vector Search with ... - Yahoo Finance
Yahoo Finance
IPA Enhances Drug Discovery with Carterra LSA - TipRanks.com - TipRanks
TipRanks
IPA Boosts AI Drug Discovery with Strategic Acquisition - TipRanks.com - TipRanks
TipRanks
ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q3 2024 Earnings Call Transcript - Yahoo Finance
Yahoo Finance
ImmunoPrecise Antibodies Ltd. (IPA) Reports Q3 Loss, Tops Revenue Estimates
Zacks Investment Research
IPA Continues Growth Streak, Slashes Cash Burn - TipRanks.com - TipRanks
TipRanks
IPA Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2024* - Business Wire
Business Wire
ImmunoPrecise Antibodies (NASDAQ:IPA) Subsidiary BioStrand Introduces Breakthrough AI Model In Life Sciences ... - AccessWire
AccessWire
Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Benzinga
IPA's subsidiary BioStrand Unveils Major Breakthrough in Life Sciences with Advanced Foundation AI Model Utilizing ... - Business Wire
Business Wire
IPA to Unveil Q3 Financials and Business Updates - TipRanks.com - TipRanks
TipRanks
IPA to Report Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2024 on March 14, 2024 - Business Wire
Business Wire
New Strong Buy Stocks for February 7th
Zacks Investment Research
New Strong Buy Stocks for February 7th - Yahoo Finance
Yahoo Finance
New Strong Buy Stocks for February 5th
Zacks Investment Research
IPA Reports Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2024* - Business Wire
Business Wire
IPA Announces Closing of $1.265 Million Public Offering of Common Shares - Business Wire
Business Wire
Gold Moves Higher; Campbell Soup Earnings Top Expectations
Benzinga
Why AeroVironment Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga
Crude Oil Down 4%; Pharvaris Shares Spike Higher
Benzinga
US Stocks Higher; Private Payrolls Rise By 103,000 In November
Benzinga
Why SentinelOne Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket
Benzinga
US Stocks Higher; Private Payrolls Rise By 103,000 In November - MicroAlgo (NASDAQ:MLGO), ImmunoPrecise A - Benzinga
Benzinga
Phreesia (PHR) Reports Q3 Loss, Tops Revenue Estimates
Zacks Investment Research
Current CFO of ImmunoPrecise Antibodies Brad McConn Resigns - CEOWORLD magazine
CEOWORLD magazine
IPA Reports Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2024 - Business Wire
Business Wire
IPA Releases New HYFT-Powered In Silico Humanization Platform, Aims to Disrupt the Transgenic Animal Model Market - BioSpace
BioSpace
ImmunoPrecise's Subsidiary Talem Enters into Exclusive Research Collaboration and License Option Agreement with ... - Business Wire
Business Wire
Talem and Libera Bio partner for discovery of AI-driven antibodies - Pharmaceutical Technology
Pharmaceutical Technology
ImmunoPrecise Antibodies' Subsidiary Talem Therapeutics Announces a Multi-Target AI-Driven Antibody Discovery ... - Business Wire
Business Wire
IPA's Subsidiary BioStrand and BriaCell Announce Artificial Intelligence Collaboration and License Agreement to ... - Business Wire
Business Wire
ImmunoPrecise Antibodies Ltd. Announces Voluntary Delisting from TSX Venture Exchange - Business Wire
Business Wire
IPA Reports Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2023 - Business Wire
Business Wire
IPA Completes Acquisition of Belgian Technology Companies BioStrand, BioKey, and BioClue – Adding Artificial ... - Business Wire
Business Wire
IPA Announces Agreement to Acquire BioStrand BV – Revolutionizing Biotherapeutics with Methodology to Encode ... - Business Wire
Business Wire
IPA Updates on Investigational New Drug (IND) Enabling Program for PolyTope® TATX-03 - Business Wire
Business Wire
Paul Andreola: ImmunoPrecise & Stock Picking In The Small Cap Arena – The Daily Dive - The Deep Dive
The Deep Dive
ImmunoPrecise Antibodies (IPA) Stock Price, News & Analysis - MarketBeat
MarketBeat
IPA Stock Price and Chart — NASDAQ:IPA — TradingView - TradingView
TradingView
ImmunoPrecise Antibodies names Yasmina Noubia Abdiche as chief scientific officer - Proactive Investors USA
Proactive Investors USA
ImmunoPrecise Launches Coronavirus Vaccine and Therapeutic Antibody Program - PR Newswire
PR Newswire
Talem Therapeutics accesses the OmniAb® platform from Ligand Pharmaceuticals - PR Newswire
PR Newswire
ImmunoPrecise guarantees success rate of its B cell Select Antibody Discovery Platform - Proactive Investors UK
Proactive Investors UK
ImmunoPrecise Antibodies on an aggressive sales and business development drive - Proactive Investors UK
Proactive Investors UK
ImmunoPrecise Antibodies collaborates with FIND to advance new tuberculosis diagnostic test - Proactive Investors UK
Proactive Investors UK
Kapitalisierung:
|
Volumen (24h):